Skip to main content
GABBROCOL 17,50G/100ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
  • AMINOSIDINA SOLFATO
  • Valid
Authorised in these countries:
  • Greece

Product identification

Medicine name:
GABBROCOL 17,50G/100ML ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance and strength:
  • AMINOSIDINA SOLFATO
    25.00
    gram(s)
    /
    100.00
    millilitre(s)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA06
Authorisation number:
  • 53483/19-07-2012/K-0113101
Product identification number:
  • 58fd41d6-981d-4592-a054-c3ba453d6cf5
Permanent identification number:
  • 600000100669

Product details

Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period

Availability

Package description:
Manufacturing sites for batch release:
  • Vetem S.p.A.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • NA
Date of authorisation status change:
Authorisation country:
  • Greece
Responsible authority:
  • National Organization For Medicines
Marketing authorisation holder:
  • Ceva Hellas LLC
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."